The Transylvania Times -

Pisgah Labs Develops Abuse Deterrent Products – Pisgah Forest NC

 


As controversy surrounds the recent FDA decisions concerning abuse deterrent forms of oxycodone drug products, Pisgah Laboratories, Inc. (www.pisgahlabs.com) has achieved another technical milestone which may radically alter the landscape for pain medication regulations.

Recently, the FDA ruled that the Abbreviated New Drug Applications (ANDAs) — competitive to Purdue Pharma’s branded Oxycodone® would no longer be considered if they did not possess abuse deterrent capability. The announcement’s timing coincided with the day Purdue’s patent for Oxycodone® expired. This regulatory...



For access to this article please sign in or subscribe.



 
 

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2019

Rendered 10/04/2019 06:30